Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
Authors:
Open Access
- 19 May 2017
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 9 (5) , e1260
Abstract
Extranodal natural killer/T-cell lymphoma (ENKTCL) is a rare form of non-Hodgkin lymphoma. This neoplasm is more prevalent in regions of Asia and Latin America and most commonly involves the sinonasal tract, presenting with signs of nasal obstruction, epistaxis, or sinus infection. It is a locally destructive and angioinvasive neoplasm. The treatment of ENKTCL is dependent on the extent of the tumor. For localized disease, the treatment is chemoradiation. For disseminated disease, treatment is mainly chemotherapy-based. This report describes a case of a 41-year-old Hispanic woman who initially presented with signs of nasal congestion for four weeks and was subsequently diagnosed and treated for chronic sinusitis. The patient underwent endoscopic surgery for persistent chronic sinusitis, with a presumptive diagnosis of allergic fungal rhinosinusitis based on clinical and radiographic presentation. The pathologic exam revealed a diagnosis of ENKTCL. The patient underwent three cycles of chemotherapy comprised of steroid (hydrocortisone), methotrexate, ifosfamide, pre-asparaginase, and etoposide (SMILE) followed by radiation, resulting in clinical and radiographic remission. On review of the literature, ENKTCL is very rare in the United States and diagnosis is commonly delayed due to non-specific signs. We report this case to increase awareness of this disease entity and remind clinicians to include this in the differential diagnosis of nasal obstruction.Keywords
This publication has 8 references indexed in Scilit:
- Hematolymphoid Lesions of the Sinonasal TractHead and Neck Pathology, 2016
- Diagnostic and therapeutic aspects in malignant sinonasal lymphoma.2016
- Imaging Case: NK/T-Cell Lymphoma, Nasal Type.2015
- Imaging Case: NK/T-Cell Lymphoma, Nasal Type2015
- Extranodal Natural-Killer/T-Cell Lymphoma, Nasal TypeAdvances in Hematology, 2010
- Advances in the management and monitoring of extranodal NK/T‐cell lymphoma, nasal typeBritish Journal of Haematology, 2009
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectBlood, 2009
- Phase I study of dexamethasone, methotrexate, ifosfamide, l ‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemiaCancer Science, 2008